30-day average of 14 articles ยท scale โ100 to +100
Across 14 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Ecolab news is Bullish (+55)
on a scale from โ100 to +100.
That is about the same as the previous 30 days (+54).
๐ Q3 sales rose 13% YoY to $4.69B with organic growth accelerating to 7%.
๐ฐ Adjusted operating income jumped 14% driven by improved leverage and efficiency.
Bullish +65
Ecolab stock enters 2027 with stronger growth and margin momentum
AI-generated analysis
Key insights
๐ Ecolab reported third-quarter sales rising 13 percent year over year to $4.69 billion, with organic growth accelerating to 7 percent.
๐ฐ Reported operating income increased 7 percent, while adjusted operating income rose 14 percent due to improved leverage.
๐ Global High-Tech organic sales surged 63 percent, and Life Sciences organic sales grew 17 percent in the third quarter.
๐ป Ecolab Digital sales climbed 34 percent to $129 million, driven by demand for water efficiency and AI infrastructure solutions.
๐ฏ Management forecasts fourth-quarter reported sales growth of 12 to 14 percent with organic growth between 6 and 7 percent.
๐ Full-year 2026 adjusted diluted earnings per share are expected to reach $8.10 to $8.20, an increase of 8 to 9 percent.
๐ฎ The company targets an adjusted operating margin of 20 percent for 2027 as acquisition-related comparisons normalize.
๐ค Acquisitions Ovivo Electronics and CoolIT are expected to add about two percentage points to annual organic sales growth.
โ๏ธ Organic operating income margin expanded 70 basis points to 19.6 percent, offsetting higher commodity costs.
๐ Adjusted diluted earnings per share increased 5 percent to $2.18 despite a 10 percent headwind from CoolIT acquisition costs.
๐ญ Ecolab positions its liquid-cooling technologies to benefit from investments in artificial intelligence and data centers.
๐ Stock traded at 277.75 euros, reflecting confidence in the margin-led earnings recovery strategy.
๐ Bullish signals
๐Reported third-quarter sales rose 13 percent year over year to $4.69 billion, demonstrating strong top-line momentum.
๐Organic sales growth accelerated to 7 percent, with volume contributing 2 percent and pricing contributing 5 percent.
๐Global High-Tech organic sales increased significantly by 63 percent, highlighting a major growth engine.
๐Life Sciences organic sales rose 17 percent, providing additional diversification and revenue stability.
๐ปEcolab Digital sales climbed 34 percent to $129 million, showcasing rapid expansion in digital solutions.
โ๏ธOrganic operating income margin expanded 70 basis points to 19.6 percent, indicating improved profitability.
๐ฏManagement expects fourth-quarter reported sales to increase 12 to 14 percent with continued organic growth.
๐Full-year 2026 adjusted diluted earnings per share are forecast at $8.10 to $8.20, an 8 to 9 percent increase.
๐ฎThe company anticipates achieving a 20 percent adjusted operating margin in 2027 as acquisition impacts fade.
๐คAcquisitions Ovivo Electronics and CoolIT are expected to add about two percentage points to annual organic sales growth.
๐ Risk factors
๐Acquisition costs, including amortization and financing from the CoolIT deal, weigh on adjusted earnings by approximately 10 percent.
๐Integration of recent acquisitions continues to affect reported profitability in the short term.
โ๏ธHigher commodity costs and growth investments require pricing and productivity gains to offset margin pressure.
๐Customer disruptions remain an important factor that could impact future revenue realization.
๐Financing costs associated with acquisitions continue to drag on net earnings despite organic growth.
Article
Ecolab Inc. reported a robust third quarter in late September 2026, characterized by accelerated organic sales growth and expanding operating margins as the company enters 2027. Reported third-quarter sales rose 13 percent year over year to $4.69 billion, driven by volume increases of 2 percent and pricing gains of 5 percent. The company highlighted significant momentum in its High-Tech and Life Sciences segments, which served as primary growth engines amidst broader market improvements.
Management provided specific guidance for the fourth quarter and full-year 2026, projecting reported sales growth between 12 to 14 percent and organic sales growth of 6 to 7 percent. For the full year 2026, Ecolab expects adjusted diluted earnings per share to reach $8.10 to $8.20, representing an 8 to 9 percent increase from the prior year. The company anticipates achieving an adjusted operating margin of approximately 20 percent in 2027 as acquisition-related amortization impacts diminish.
Strategic acquisitions, specifically Ovivo Electronics and CoolIT, are expected to contribute roughly two percentage points to annual organic sales growth within a year of closing. While these deals drive future revenue expansion, they currently weigh on reported profitability due to integration costs and financing expenses. The company's focus remains on water efficiency solutions and liquid-cooling technologies to capitalize on investments in artificial intelligence infrastructure and data centers.
Ecolab stock traded at 277.75 euros on November 12, 2026, reflecting investor confidence in the margin-led earnings recovery despite ongoing headwinds from commodity prices and customer disruptions. The operating update strengthens the case for sustained profitability improvements as the company successfully integrates new technologies and navigates macroeconomic factors affecting its industrial base.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Ecolab Inc. reported a robust third quarter in late September 2026, characterized by accelerated organic sales growth and expanding operating margins as the company enters 2027. Reported third-quarter sales rose 13 percent year over year to $4.69 billion, driven by volume increases of 2 percent and pricing gains of 5 percent. The company highlighted significant momentum in its High-Tech and Life Sciences segments, which served as primary growth engines amidst broader market improvements.
Management provided specific guidance for the fourth quarter and full-year 2026, projecting reported sales growth between 12 to 14 percent and organic sales growth of 6 to 7 percent. For the full year 2026, Ecolab expects adjusted diluted earnings per share to reach $8.10 to $8.20, representing an 8 to 9 percent increase from the prior year. The company anticipates achieving an adjusted operating margin of approximately 20 percent in 2027 as acquisition-related amortization impacts diminish.
Strategic acquisitions, specifically Ovivo Electronics and CoolIT, are expected to contribute roughly two percentage points to annual organic sales growth within a year of closing. While these deals drive future revenue expansion, they currently weigh on reported profitability due to integration costs and financing expenses. The company's focus remains on water efficiency solutions and liquid-cooling technologies to capitalize on investments in artificial intelligence infrastructure and data centers.
Ecolab stock traded at 277.75 euros on November 12, 2026, reflecting investor confidence in the margin-led earnings recovery despite ongoing headwinds from commodity prices and customer disruptions. The operating update strengthens the case for sustained profitability improvements as the company successfully integrates new technologies and navigates macroeconomic factors affecting its industrial base.
๐ Q3 sales rose 13% YoY to $4.69B with organic growth accelerating to 7%.
๐ฐ Adjusted operating income jumped 14% driven by improved leverage and efficiency.
๐ High-Tech and Life Sciences segments surged 63% and 17% organically respectively.
๐ฏ Q4 sales forecasted at 12-14% growth with full-year EPS expected $8.10-$8.20.
๐ฎ Targets 20% adjusted operating margin for 2027 as acquisitions normalize.
๐ Ecolab reported third-quarter sales rising 13 percent year over year to $4.69 billion, with organic growth accelerating to 7 percent.
๐ฐ Reported operating income increased 7 percent, while adjusted operating income rose 14 percent due to improved leverage.
๐ Global High-Tech organic sales surged 63 percent, and Life Sciences organic sales grew 17 percent in the third quarter.
๐ป Ecolab Digital sales climbed 34 percent to $129 million, driven by demand for water efficiency and AI infrastructure solutions.
๐ฏ Management forecasts fourth-quarter reported sales growth of 12 to 14 percent with organic growth between 6 and 7 percent.
๐ Full-year 2026 adjusted diluted earnings per share are expected to reach $8.10 to $8.20, an increase of 8 to 9 percent.
๐ฎ The company targets an adjusted operating margin of 20 percent for 2027 as acquisition-related comparisons normalize.
๐ค Acquisitions Ovivo Electronics and CoolIT are expected to add about two percentage points to annual organic sales growth.
โ๏ธ Organic operating income margin expanded 70 basis points to 19.6 percent, offsetting higher commodity costs.
๐ Adjusted diluted earnings per share increased 5 percent to $2.18 despite a 10 percent headwind from CoolIT acquisition costs.
๐ญ Ecolab positions its liquid-cooling technologies to benefit from investments in artificial intelligence and data centers.
๐ Stock traded at 277.75 euros, reflecting confidence in the margin-led earnings recovery strategy.
Bullish Signals
Q3 sales rose 13% YoY to $4.69B.
Organic sales grew 7%, driven by volume and pricing.
High-Tech organic sales surged 63%.
Life Sciences organic sales up 17%.
Digital sales climbed 34% to $129M.
Operating margin expanded 70bps to 19.6%.
Q4 sales expected up 12-14%.
FY2026 EPS forecast at $8.10-$8.20.
2027 adjusted operating margin targets 20%.
Acquisitions add ~2pp to organic growth.
Risk Factors
Acquisition costs weigh on adjusted earnings by ~10%.
Ecolab Inc. is entering 2027 with strengthened operating momentum following a broad improvement in its third-quarter performance, which management views as an inflection point for the company's core businesses and growth engines. Reported sales rose 13% in the quarter ended September 30, while organic sales growth accelerated to 7%, driven by significant gains in specific segments. Global High-Tech delivered a robust 63% organic sales growth, Life Sciences grew organically by 17%, and Ecolab Digital sales increased 34% to reach $129 million, establishing a new technology-led channel within the portfolio.
Financial metrics for the quarter reflected this operational acceleration, with organic operating income rising 11% and the organic operating income margin expanding to 19.6%. This improvement was supported by pricing that accelerated to 5%, which helped offset higher commodity costs, alongside enhanced productivity. While reported diluted earnings per share fell 5% to $1.95 due to acquisition-related amortization and financing costs acting as a near-term headwind, adjusted diluted earnings per share increased 5% to $2.18. The company's stock traded at 274.30 euros on November 10, 2026.
Looking ahead, management expects 2027 organic sales growth to be at the upper end of its 5% to 7% target range and an adjusted operating income margin of 20%. Adjusted earnings growth is anticipated to accelerate in the second half of the year as the company moves beyond the initial effects of its acquisitions. For 2026, Ecolab projects adjusted diluted earnings per share between $8.10 and $8.20, with fourth-quarter adjusted diluted earnings per share projected at $2.13 to $2.23. The outlook remains sensitive to CoolIT-related amortization and financing costs, though the company expects a fourth-quarter adjusted operating margin of approximately 19% and an organic operating margin of approximately 20%.
๐ Q3 sales rose 13% with organic growth accelerating to 7%.
๐ High-Tech segment surged 63% while Life Sciences grew 17%.
๐ป Digital sales jumped 34% to $129 million, creating new growth.
๐ Organic operating income up 11% as margins expanded to 19.6%.
Company updateDividendEarnings reportAI-generated analysis
Ecolab Inc. ($ECL) is a global market leader in water, hygiene, and infection prevention solutions serving foodservice, healthcare, hospitality, and industrial sectors. The company combines chemical formulations with digital monitoring and services to improve operational performance while reducing resource consumption. Analysts view the business as having durable revenue growth driven by pricing power and strong demand for consumables across its end markets.
Financially, Ecolab reported trailing revenue of approximately $17.4 billion with low double-digit year-over-year growth. Gross margins remain resilient in the mid-40s percentage range, reflecting a favorable product mix. However, recent earnings have been mixed; while EPS matched consensus estimates, it was flagged as a miss relative to implied expectations, and year-over-year earnings growth turned negative due to margin compression and cost pressures.
The stock trades at a premium valuation with a trailing P/E of 40.58 and a forward P/E near 32, significantly above typical industrial multiples. The company carries meaningful leverage with total debt around $13.94 billion against roughly $0.72 billion in cash, resulting in a debt-to-equity ratio of approximately 133%. Despite this leverage, operating cash flow remains robust at $3.03 billion, generating over $1.4 billion in free cash flow on a trailing basis.
Analysts maintain a broadly positive stance with a consensus rating of Strong Buy and a mean price target near $328, implying single-digit upside from the current price of $300.68. The investment thesis hinges on management's ability to execute margin recovery and convert digital initiatives into meaningful earnings growth to justify the elevated multiple. A fair value band is estimated between $310 and $340 per share based on blended analyst targets and DCF models.
๐ Ecolab leads water hygiene market with durable revenue growth from pricing power.
๐ฐ Trailing revenue hit $17.4B with gross margins near mid-40s percentage range.
โ ๏ธ EPS matched consensus but missed implied expectations with negative year-over-year earnings growth.
๐ฆ Total debt stands at $13.94B against $0.72B cash for elevated leverage ratio.
๐ต Operating cash flow of $3.03B generates over $1.4B free cash flow trailing basis.
๐ Ecolab ($ECL) is a market leader in water, hygiene, and infection prevention with durable revenue growth driven by pricing power and strong consumables demand.
๐ฐ The company reported trailing revenue of $17.4B with gross margins near the mid-40s percentage range, indicating resilient product mix and pricing strength.
โ ๏ธ Recent earnings were mixed as EPS matched consensus but was flagged as a miss versus implied expectations, with negative year-over-year earnings growth.
๐ฆ Ecolab carries meaningful leverage with total debt of $13.94B and cash of $0.72B, resulting in an elevated debt-to-equity ratio of roughly 133%.
๐ต Operating cash flow remains a strength at $3.03B, generating over $1.4B in free cash flow on a trailing basis to service debt and fund investments.
๐ The stock trades at a premium valuation with a trailing P/E of 40.58 and a forward P/E near 32, well above typical industrial multiples.
๐ฏ Analysts maintain a Strong Buy consensus rating with a mean price target near $328, implying single-digit upside from the current price of $300.68.
๐ฎ A fair value band is estimated between $310 and $340 per share based on blended analyst targets and conservative DCF assumptions.
๐ Management emphasizes margin recovery and the deployment of digital solutions to drive higher-value services and validate the current premium multiple.
๐ The next quarterly report is expected in late January to February 2027, with focus on fiscal guidance and order book updates.
Bullish Signals
Market leader with durable revenue growth from pricing power.
Gross margins resilient in mid-40s range via product mix.
Operating cash flow $3.03B funds debt and investments.
Dividend Aristocrat status shows consistent payout growth history.
Analyst consensus Strong Buy with mean target near $328.
YoY earnings growth turned negative due to margin compression.
Trades at premium P/E of 40.58 vs sector multiples.
High leverage with $13.94B debt and 133% debt-to-equity.
Liquidity strained with current ratio near 1.11.
Bullish Signals
Ecolab is a market leader in water, hygiene, and infection prevention with durable revenue growth driven by pricing power and strong consumables demand.
Gross margins remain resilient in the mid-40s percentage range, reflecting a favorable product mix and strong pricing power across end markets.
Operating cash flow remains a significant strength at $3.03B, generating over $1.4B in free cash flow on a trailing basis to service debt and fund investments.
The company holds inclusion in the Dividend Aristocrats feature, demonstrating a history of consistent payout growth.
Analysts maintain a broadly positive stance with a consensus rating of Strong Buy and a mean price target near $328.
Risk Factors
Recent earnings were mixed as EPS matched consensus but was flagged as a miss versus the company's implied expectations.
Year-over-year earnings growth turned negative due to margin compression and cost pressures weighing on profitability despite revenue gains.
The stock trades at a premium valuation with a trailing P/E of 40.58, significantly above typical industrial and basic materials multiples.
The company carries meaningful leverage with total debt around $13.94B and cash around $0.72B, resulting in an elevated debt-to-equity ratio of roughly 133%.
Liquidity metrics show a current ratio near 1.11 and a quick ratio below 1 at roughly 0.77, highlighting working capital management challenges.
AI infrastructureCooling technologyAI-generated analysis
Ecolab Inc. is positioning its water and energy efficiency solutions as a strategic growth area linked to the expanding artificial intelligence infrastructure sector. At an event during Climate Week NYC, Ecolab's Chief Sustainability Officer Emilio Tenuta highlighted how AI data centers and semiconductor manufacturing are driving rising demands for water, power, and cooling, creating a need for circular resource systems.
The company views this shift from linear to circular resource use as a potential avenue to apply its existing treatment, monitoring, and efficiency solutions. This strategic narrative connects Ecolab's core industrial businesses in hygiene and infection prevention with the fast-expanding context of data center operations, suggesting a new market angle for its technology portfolio.
However, management explicitly noted that this development adds a sustainability and infrastructure dimension to the investment case rather than altering the immediate financial outlook. The realization of this opportunity remains dependent on customer investment levels, the rate of technology adoption, and Ecolab's ability to scale its services effectively within this new industrial context.
๐ Ecolab links AI growth to rising water, energy, and cooling demands.
๐ง CSO Tenuta advocates shifting from linear to circular resource systems.
โ๏ธ Company offers treatment and efficiency solutions for growing computing capacity.
๐ Commercial execution is the primary hurdle for this growth field.
๐ฐ Sustainability angle added without changing near-term financial outlook.
๐ Ecolab links AI infrastructure growth with rising demands for water, energy, and data-center cooling solutions.
๐ง Chief Sustainability Officer Emilio Tenuta argues technology can enable a shift from linear to circular resource use systems.
๐ญ Data-center cooling and semiconductor production require integrated management of water availability and operating reliability.
โ๏ธ Ecolab sees an opportunity to apply its treatment, monitoring, and efficiency solutions as computing capacity grows.
๐ Commercial execution remains the primary hurdle for realizing this potential growth field in AI infrastructure.
๐ฐ The event adds a sustainability angle to the investment case without changing the company's near-term financial outlook.
Bullish Signals
AI infrastructure drives water/energy efficiency growth.
Solutions fit data-center cooling and chipmaking.
Risk Factors
Growth depends on external customer investment, not guaranteed internal demand.
Bullish Signals
Ecolab identifies a strategic growth opportunity by linking its water and energy efficiency solutions to the expanding artificial intelligence infrastructure sector.
The company positions its treatment, monitoring, and efficiency solutions as applicable to the rising demands of data-center cooling and semiconductor manufacturing.
Risk Factors
The realization of growth in AI infrastructure remains dependent on external customer investment and technology adoption rates rather than guaranteed internal demand.
Company updateEarnings reportAI-generated analysis
Ecolab Inc. reported a strong third-quarter performance characterized by significant sales growth and margin expansion, marking an inflection point for the water and hygiene specialist. Third-quarter sales increased 13 percent year-over-year to $4.69 billion, driven by volume growth of 2 percent and pricing acceleration of 5 percent. Organic sales growth accelerated to 7 percent, while organic operating income grew 11 percent, expanding the organic operating margin to 19.6 percent.
Management provided updated guidance for fiscal year 2027, projecting organic sales growth at the upper end of its 5 percent to 7 percent target range and an adjusted operating margin of 20 percent. The company expects pricing and productivity gains to continue offsetting higher commodity costs and investments in acquisitions. CEO Christophe Beck highlighted that acquisition-related amortization and financing costs currently create a headwind, but these effects are expected to diminish in the second half of 2027.
Specific business segments showed robust growth, with Global High-Tech organic sales surging 63 percent and Life Sciences organic sales increasing 17 percent. Key acquisitions Ovivo Electronics and CoolIT are performing strongly and are projected to contribute approximately two percentage points to annual organic sales growth within one year of closing. For the full year 2026, Ecolab expects adjusted diluted earnings per share between $8.10 and $8.20, representing an 8 percent to 9 percent increase.
The stock traded at 271.75 euros on November 2, 2026, reflecting investor confidence in the company's execution and long-term growth targets of 12 percent to 15 percent adjusted earnings growth. Investors will closely monitor fourth-quarter execution, the integration pace of the CoolIT acquisition, and the ability to maintain pricing power against inflationary pressures.
๐ Q3 sales rose 13% to $4.69B with organic growth accelerating to 7%.
๐ฐ Organic operating income grew 11% to $872.1M, expanding margin to 19.6%.
๐ฏ Management forecasts 2027 organic sales at upper end of 5-7% range.
๐ Global High-Tech segment achieved exceptional 63% organic sales growth in Q3.
Ecolab (NYSE: ECL) has emerged as a top-performing industrial stock, surging over 16% in 2024 and rising 44% over the past year to reach record highs. As a dividend aristocrat with 31 consecutive years of payout increases, the company demonstrates strong momentum, outperforming major indices like the Nasdaq 100 and S&P 500 despite technical indicators suggesting it is currently overbought.
Fundamentally, Ecolab has expanded its revenue from $12.7 billion in 2021 to $15.3 billion in 2023, driven by organic growth and the acquisition of Purolite for $3.7 billion. The company's profitability has recovered significantly from a $12 billion loss in 2020 to $1.3 billion in 2023, with recent Q4 results showing a 7% revenue increase to $3.95 billion.
Analysts remain largely bullish on Ecolab's long-term prospects, citing its near-monopoly position in key industries and deep relationships with major corporate clients. Management expects adjusted earnings between $6.10 and $6.50 for the current year, though the stock trades at a premium valuation with a forward PE ratio of 36.12 compared to a sector median of 16.8.
๐ Ecolab stock surged over 16% in 2024 to all-time highs.
๐ฐ Dividend aristocrat with payouts increased for 31 consecutive years.
๐ Revenue grew from $12.7B to $15.3B aided by Purolite deal.
โ ๏ธ Trades at premium forward PE of 36.12 versus sector median.
๐ Technicals suggest potential short-term pullback to $200 support level.
๐ Ecolab stock has surged over 16% in 2024 and reached all-time highs, outperforming the Nasdaq 100 and S&P 500.
๐ฐ The company is a dividend aristocrat that has increased its payouts for over 31 consecutive years.
๐ Revenue grew from $12.7 billion in 2021 to $15.3 billion in 2023, aided by the $3.7 billion acquisition of Purolite.
๐ Profitability recovered from a $12 billion loss in 2020 to $1.3 billion in 2023, with Q4 revenue rising 7% to $3.95 billion.
๐ฏ Management forecasts annual adjusted earnings between $6.10 and $6.50 for the current year.
๐ Ecolab holds a near-monopoly position in key industries like water, food, beverage, and paper with deep client relationships.
โ ๏ธ The stock trades at a premium valuation with a forward PE ratio of 36.12 versus a sector median of 16.8.
๐ Technical indicators show the stock is overbought with RSI above levels, suggesting a potential short-term pullback to $200.
๐ฅ Analyst sentiment is mixed but generally positive, with 12 buy ratings versus 9 underperform views among 22 trackers.
Bullish Signals
Stock surged 16% in 2024 to all-time highs.
Dividend increased for 31 consecutive years.
Revenue grew from $12.7B to $15.3B.
Profit recovered from $12B loss to $1.3B.
Q4 revenue rose 7% to $3.95B.
Risk Factors
Trades at high forward PE of 36.12 vs sector median 16.8.
Overbought RSI suggests potential short-term pullback to $200.
Bullish Signals
Ecolab stock has surged over 16% in 2024 and reached all-time highs, outperforming major indices like the Nasdaq 100.
The company is a dividend aristocrat that has increased its payouts for over 31 consecutive years, signaling financial stability.
Revenue grew from $12.7 billion in 2021 to $15.3 billion in 2023, driven by organic growth and the strategic acquisition of Purolite.
Profitability has recovered significantly from a $12 billion loss in 2020 to $1.3 billion in 2023, with Q4 revenue rising 7% to $3.95 billion.
Management expects annual adjusted earnings between $6.10 and $6.50, indicating continued growth expectations.
Ecolab holds a near-monopoly position in key industries like water, food, beverage, and paper with deep relationships with major corporate clients.
Risk Factors
The stock trades at a premium valuation with a forward PE ratio of 36.12 compared to a sector median of 16.8.
Technical indicators show the stock is overbought with RSI above levels, suggesting a potential short-term pullback to $200.
Ecolab Inc. reported robust third-quarter execution with sales rising 13 percent to USD 4.69 billion, driven by a 2 percent volume increase and a 5 percent price hike. Organic sales growth accelerated to 7 percent, reflecting improved underlying business performance across its industrial hygiene and food safety segments.
Management highlighted significant operational improvements, noting that organic operating income grew 11 percent while the margin expanded 70 basis points to 19.6 percent. Adjusted diluted earnings per share increased 5 percent to USD 2.18, though this figure was impacted by approximately 10 percent headwinds from acquisition-related amortization and financing costs associated with the CoolIT and Ovivo Electronics deals.
Looking ahead, Ecolab raised its full-year 2026 adjusted diluted earnings per share guidance to a range of USD 8.10 to USD 8.20, representing an 8 percent to 9 percent increase. The company projects fourth-quarter sales growth between 12 percent and 14 percent with organic growth expected at 6 percent to 7 percent as acquisition integration costs begin to normalize.
For the fiscal year 2027, Ecolab expects organic sales growth to reach the upper end of its 5 percent to 7 percent target range alongside an adjusted operating income margin of 20 percent. Management anticipates that earnings growth will accelerate in the second half of the year as acquisition-related effects become easier to absorb, supporting a long-term adjusted earnings growth target of 12 percent to 15 percent.
๐ Ecolab Q3 sales grew 13% total and 7% organically to USD 4.69 billion.
๐ฐ Operating income rose 11% with margins expanding to 19.6%.
๐ฎ Full-year 2026 EPS guidance raised to USD 8.10-$8.20.
๐ฏ FY2027 targets include 5-7% organic sales growth and 20% operating margin.
๐ Long-term earnings growth expected to accelerate toward 12-15%.
๐ Ecolab reported 13 percent total sales growth and 7 percent organic sales growth in the third quarter.
๐ฐ Reported sales reached USD 4.69 billion, driven by a 2 percent volume increase and a 5 percent price increase.
๐ Organic operating income grew 11 percent with margins expanding 70 basis points to 19.6 percent.
๐ Adjusted diluted earnings per share rose 5 percent to USD 2.18 despite a 10 percent headwind from CoolIT acquisition costs.
๐ฎ Full-year 2026 adjusted diluted EPS guidance is raised to USD 8.10-$8.20, representing 8-9 percent growth.
๐ Fourth-quarter sales are forecast to grow 12-14 percent with organic growth of 6-7 percent.
๐ฏ Ecolab targets an upper-end 5-7 percent organic sales growth rate for fiscal year 2027.
๐ผ Management projects a 20 percent adjusted operating income margin for the 2027 fiscal year.
๐ Long-term adjusted earnings growth is expected to accelerate toward a 12-15 percent target as acquisition costs normalize.
๐ญ The company successfully integrated Ovivo Electronics and CoolIT deals, though amortization remains a short-term factor.
Bullish Signals
Sales rose 13% to USD 4.69B in Q3.
Risk Factors
CoolIT deal caused ~10% headwind to adjusted EPS.
Ovivo and CoolIT integration costs hurt short-term earnings.
Bullish Signals
Ecolab achieved strong third-quarter execution with reported sales rising 13 percent to USD 4.69 billion.
Organic sales growth accelerated to 7 percent as volume growth improved to 2 percent and pricing increased 5 percent.
Organic operating income increased 11 percent while the organic operating income margin expanded 70 basis points to 19.6 percent.
Adjusted diluted earnings per share rose 5 percent to USD 2.18, demonstrating resilient profitability despite acquisition headwinds.
Management raised full-year 2026 adjusted diluted EPS guidance to a range of USD 8.10 to USD 8.20.
The company forecasts fourth-quarter sales growth between 12 percent and 14 percent with organic growth of 6 percent to 7 percent.
Ecolab expects organic sales growth for 2027 to reach the upper end of its 5 percent to 7 percent target range.
Management projects an adjusted operating income margin of 20 percent for fiscal year 2027.
Adjusted earnings growth is expected to accelerate in the second half of the year as acquisition-related effects become easier to absorb.
The company supports its long-term target of 12 percent to 15 percent adjusted earnings growth with current performance trends.
Risk Factors
CoolIT acquisition-related amortization and financing costs created an approximate 10 percent headwind to reported adjusted diluted earnings per share.
Acquisition integration costs from the Ovivo Electronics and CoolIT deals continue to weigh on short-term earnings performance.
Ecolab Inc. reported strong third-quarter 2026 results, driven by broad-based operating momentum and margin expansion despite higher commodity costs. Sales reached USD 4.6948 billion, representing a 13 percent year-over-year increase, while adjusted diluted earnings per share rose 5 percent to USD 2.18. The company successfully navigated acquisition-related headwinds to demonstrate underlying profitability improvements.
Organic operating income margin expanded significantly to 19.6 percent from 18.9 percent a year earlier, with organic operating income increasing by 11 percent. Adjusted operating income rose 14 percent to USD 893.4 million, highlighting the strength of core business operations even as the company continues to invest in growth initiatives and manage integration costs from recent acquisitions.
Newer growth segments are contributing meaningfully to overall performance, with Global High-Tech organic sales surging 63 percent, Life Sciences growing 17 percent, and Ecolab Digital sales increasing 34 percent. Management maintains a positive outlook for 2026, expecting adjusted diluted earnings per share between USD 8.10 and USD 8.20, and anticipates accelerating growth in the second half of the year as acquisition effects normalize.
For 2027, Ecolab targets organic sales growth at the upper end of its 5 to 7 percent range and aims to reach a 20 percent adjusted operating income margin. The company expects continued deleveraging after acquisitions and remains focused on integration success, positioning itself for sustained profitability improvements as acquisition-related amortization and financing expenses become less impactful.
๐ Ecolab Q3 sales rose 13% to $4.69B, up 13% year over year.
๐ฐ Adjusted EPS grew 5% to $2.18 despite acquisition-related headwinds.
๐ Global High-Tech organic sales surged 63%, showing strong new growth momentum.
๐ฏ Management expects 2026 adjusted diluted EPS between $8.10 and $8.20.
๐ฎ 2027 outlook targets upper-end organic sales growth of 5-7 percent.
๐ Ecolab reported Q3 2026 sales of USD 4.6948 billion, up 13 percent year over year.
๐ฐ Adjusted diluted earnings per share rose 5 percent to USD 2.18 despite acquisition-related headwinds.
๐ Organic operating income margin expanded to 19.6 percent from 18.9 percent a year earlier.
๐ Global High-Tech organic sales surged 63 percent, indicating strong momentum in new growth areas.
๐ฌ Life Sciences segment grew organically by 17 percent, contributing to diversified revenue streams.
๐ป Ecolab Digital sales increased 34 percent to USD 129 million, reflecting digital transformation success.
๐ฏ Management expects 2026 adjusted diluted EPS between USD 8.10 and USD 8.20 (8-9% growth).
๐ Q4 2026 guidance projects organic operating income margin near 20 percent.
๐ฎ 2027 outlook targets upper-end organic sales growth of 5-7 percent and 20 percent operating margin.
โ๏ธ Acquisition-related amortization created a 10 percentage point headwind to adjusted earnings growth in Q3.
๐ Reported diluted EPS declined to USD 1.95 due to non-operating factors like acquisition costs.
๐ญ Company continues investment in growth areas despite higher commodity costs impacting margins.
Bullish Signals
Sales rose 13% to USD 4.69B in Q3 2026.
Risk Factors
Acquisition costs caused 10 percentage point earnings headwind in Q3.
Bullish Signals
Ecolab achieved a 13 percent year-over-year sales increase, reaching USD 4.6948 billion in Q3 2026.
Organic operating income margin expanded to 19.6 percent from 18.9 percent, demonstrating improved profitability.
Adjusted operating income rose 14 percent to USD 893.4 million despite higher commodity costs and continued investment.
Global High-Tech organic sales surged 63 percent, signaling strong growth in emerging market segments.
Life Sciences segment grew organically by 17 percent, diversifying the company's revenue base.
Ecolab Digital sales increased 34 percent to USD 129 million, highlighting successful digital expansion.
Management expects 2026 adjusted diluted EPS growth of 8-9 percent, targeting USD 8.10 to USD 8.20.
Q4 2026 guidance projects organic operating income margin near 20 percent, indicating continued margin improvement.
Company anticipates accelerating earnings growth in the second half of 2026 as acquisition effects normalize.
2027 outlook targets upper-end organic sales growth within the 5-7 percent range and a 20 percent operating margin.
Risk Factors
Acquisition-related amortization and financing expenses created an approximate 10 percentage point headwind to adjusted earnings growth in Q3.
Reported diluted EPS declined to USD 1.95 due to non-operating factors like acquisition costs, masking underlying operational strength.
Higher commodity costs continue to impact margins, requiring ongoing management attention and cost control measures.
Outlook remains dependent on successful integration of acquisitions and effective deleveraging after recent purchases.
Ecolab (ECL) reported Q3 2026 earnings that confirmed its status as a premium operator in global water, hygiene, and specialty chemicals. Despite trading at a high P/E of 39.2x, the stock edged up 0.8% to roughly US$291 after releasing results that showed significant operational strength. The company highlighted organic operating income margins reaching 19.6%, driven by resilient pricing and productivity that outpaced revenue growth amidst persistent commodity inflation.
The core narrative centers on Ecolab's strategic inflection point where high-growth segments are lifting overall profitability. Key verticals like Global High-Tech surged 63%, Digital grew 34%, and Life Sciences expanded 17%. However, these gains were partially offset by the integration of CoolIT and elevated capital expenditures, which resulted in a year-over-year decline in net income (down 5.8%) and basic EPS (down 4.7%).
Management explicitly acknowledged that heavy spending on acquisitions and CapEx is currently constraining free cash flow and delaying improvements in returns on invested capital. The company aims to push group operating margins toward at least 20% by sustaining high growth in specialty segments while integrating CoolIT, Ovivo, and Purolite. Analysts note that the EPS drag from the CoolIT acquisition reduces adjusted earnings by approximately US$0.20 per quarter in the second half of 2026.
๐ Q3 revenue surged 12.7% to US$4,694.8 million with organic margin at 19.6%.
๐ High-Tech segment expanded 63% while Digital and Life Sciences grew 34% and 17%.
โ ๏ธ Net income dropped 5.8% due to CoolIT acquisition integration costs.
๐ Basic EPS fell 4.7% to US$1.97 amid higher borrowing costs and CapEx.
๐๏ธ Management aims for 20% operating margins despite CoolIT reducing adjusted EPS by US$0.20/quarter.
๐ Ecolab achieved a 12.7% revenue increase to US$4,694.8 million in Q3 2026 compared to the prior year.
๐ฐ Organic operating income margin reached 19.6%, demonstrating strong pricing power and productivity gains against inflation.
๐ Global High-Tech segment grew impressively by 63%, while Digital and Life Sciences segments grew 34% and 17% respectively.
โ ๏ธ Net income declined 5.8% to US$551.3 million due to the EPS drag from the CoolIT acquisition integration.
๐ Basic EPS fell 4.7% to US$1.97, reflecting higher borrowing costs and elevated capital expenditures around 7% of sales.
๐๏ธ Management targets lifting group operating margins toward at least 20% through successful execution of high CapEx and acquisitions.
๐ธ The CoolIT acquisition is reducing adjusted EPS by approximately US$0.20 per quarter in the second half of 2026.
๐ Ecolab cut its 2026 adjusted EPS guidance range following higher borrowing requirements for the CoolIT deal.
Bullish Signals
Organic operating income margin reached 19.6%.
Global High-Tech segment surged 63% year-over-year.
Digital segment grew 34% year-over-year.
Integrating CoolIT, Ovivo, and Purolite for digital leadership.
Risk Factors
Net income and EPS declined 5.8% and 4.7% YoY.
High capex and CoolIT acquisition limit near-term free cash flow.
CoolIT integration reduces adjusted EPS by $0.20/quarter in H2 2026.
Bullish Signals
Organic operating income margin reached 19.6%, validating the company's resilient earnings power and ability to maintain pricing amidst commodity inflation.
High-growth specialty segments delivered exceptional performance, with Global High-Tech surging 63% and Digital growing 34% year-over-year.
The company is executing its strategy to integrate CoolIT, Ovivo, and Purolite, positioning itself as a leader in digital infrastructure solutions.
Risk Factors
Net income and basic EPS declined year-over-year by 5.8% and 4.7% respectively, indicating that investment costs are currently outweighing top-line growth benefits.
Elevated capital expenditures at around 7% of sales combined with the CoolIT acquisition are limiting near-term free cash flow generation.
The integration of CoolIT is reducing adjusted EPS by approximately US$0.20 per quarter in the second half of 2026, delaying expected improvements in returns on invested capital.
Ecolab (ECL) reported third-quarter earnings of $2.18 per share, which matched the Zacks Consensus Estimate after adjusting for non-recurring items. This represents an increase from $2.07 per share a year ago. Revenue for the quarter ended September 2026 reached $4.69 billion, surpassing analyst expectations by 0.49% and exceeding the prior year's revenue of $4.17 billion.
The company has demonstrated consistent performance against consensus estimates, topping revenue projections four times over the last four quarters and beating earnings estimates twice during that same period. Despite these solid operational results, Ecolab shares have underperformed the broader market this year, rising approximately 10.1% compared to the S&P 500's gain of 12.1%.
Analyst sentiment remains cautious ahead of future earnings releases, with the stock currently holding a Zacks Rank #4 (Sell) due to unfavorable estimate revisions trends prior to this report. The consensus outlook for the coming quarter projects $2.20 in EPS and $4.73 billion in revenue, while the full-year fiscal year estimates stand at $8.16 per share and $17.96 billion in total revenue.
Investors are advised to monitor management commentary on the earnings call for further guidance, as the sustainability of the stock's price movement will largely depend on future expectations. The broader Chemical - Specialty industry is currently ranked in the bottom 33% of all Zacks industries, which historically correlates with underperformance relative to the top half of the sector.
๐ Q3 EPS of $2.18 matched analyst estimates after adjustments.
๐ฐ Revenue hit $4.69 billion, beating expectations by 0.49%.
๐ Ecolab topped revenue estimates for four consecutive quarters.
๐ Shares gained 10.1% this year, underperforming the S&P 500.
โ ๏ธ Stock holds Zacks Rank #4 due to negative estimate revisions.
๐ Ecolab reported Q3 earnings of $2.18 per share, matching analyst consensus estimates after non-recurring adjustments.
๐ฐ Quarterly revenue reached $4.69 billion, beating expectations by 0.49% and growing year-over-year to $4.17 billion.
๐ The company has topped consensus revenue estimates four times over the last four consecutive quarters.
๐ Ecolab shares have underperformed the S&P 500 this year, gaining 10.1% versus the index's 12.1% return.
โ ๏ธ The stock currently holds a Zacks Rank #4 (Sell) due to unfavorable earnings estimate revisions trends.
๐ฎ Analysts project $2.20 EPS and $4.73 billion revenue for the upcoming quarter based on current consensus.
๐ญ Ecolab operates within the Chemical - Specialty industry, which is currently ranked in the bottom 33% of all Zacks industries.
Bullish Signals
Q3 EPS of $2.18 matched analyst consensus estimates.
Risk Factors
Shares underperformed S&P 500, rising only 10.1% vs 12.1% gain.
Holds Zacks Rank #4 (Sell) due to unfavorable earnings revisions.
Bullish Signals
Ecolab delivered Q3 earnings of $2.18 per share, matching analyst consensus estimates after adjusting for non-recurring items.
The company posted quarterly revenue of $4.69 billion, surpassing the Zacks Consensus Estimate by 0.49%.
Ecolab has topped consensus revenue estimates four times over the last four quarters, demonstrating consistent performance.
Year-over-year earnings increased from $2.07 per share to $2.18 per share, reflecting solid organic growth.
Risk Factors
Ecolab shares have underperformed the S&P 500 this year, rising only 10.1% compared to the index's 12.1% gain.
The stock currently holds a Zacks Rank #4 (Sell) due to unfavorable earnings estimate revisions trends prior to the report.
UBS Group raised its price target for Ecolab Inc. to USD 344 on October 5, 2026, ahead of the company's scheduled third-quarter earnings release. This bullish adjustment comes as part of a generally positive analyst consensus, with MarketBeat reporting an average target of USD 324.50 and a Moderate Buy rating. UBS's specific estimate sits notably above the group average, signaling strong confidence in Ecolab's near-term prospects.
Ecolab reported robust second-quarter financial performance, generating USD 4.42 billion in revenue, which represents a 9.70% year-over-year increase. The company also delivered quarterly earnings per share of USD 2.09, slightly beating the consensus estimate of USD 2.08. These results demonstrate solid operational growth and profitability that support the elevated analyst price targets.
Looking forward, Ecolab is scheduled to release its third-quarter results on October 27, 2026, with a webcast beginning at 1:00 p.m. Eastern Time. The upcoming earnings report will be critical in determining whether the company can sustain its recent growth trajectory and validate the bullish outlook provided by UBS and other analysts. Current market data shows Ecolab trading around EUR 259.45 with a market capitalization of approximately USD 80.9 billion.
๐ UBS raised ECL price target to $344 ahead of Q3 earnings.
๐ฐ ECL reported Q2 revenue of $4.42B, up 9.70% year-over-year.
๐ ECL beat Q2 EPS estimates with $2.09 versus $2.08 consensus.
๐ญ ECL guides Q3 EPS between $2.13 and $2.23 per share.
๐ ECL releases Q3 results and hosts webcast on October 27, 2026.
๐ UBS raised its price target for Ecolab to USD 344 on October 5, 2026, ahead of the third-quarter earnings release.
๐ฐ Ecolab reported second-quarter revenue of USD 4.42 billion, marking a 9.70% year-over-year increase.
๐ The company achieved quarterly earnings per share of USD 2.09, beating the consensus estimate of USD 2.08.
๐ญ Ecolab provided third-quarter earnings guidance ranging from USD 2.13 to USD 2.23 per share.
๐ The company is scheduled to release its Q3 results and host a webcast on October 27, 2026.
๐ข Ecolab operates in the Basic Materials / Specialty Chemicals sector with a market capitalization of USD 80.9 billion.
๐ The stock closed at USD 288.53 on October 23, 2026, within a 52-week range of USD 243.15 to USD 309.27.
Bullish Signals
UBS raised price target to $344 on Oct 5, 2026.
Q2 revenue grew 9.70% YoY to $4.42 billion.
EPS of $2.09 beat consensus estimate of $2.08.
Bullish Signals
UBS raised its price target for Ecolab to USD 344 on October 5, 2026, signaling strong analyst confidence ahead of earnings.
Ecolab generated USD 4.42 billion in second-quarter revenue, a significant 9.70% year-over-year increase demonstrating robust growth.
The company delivered quarterly earnings per share of USD 2.09, which beat the consensus estimate of USD 2.08.
Ecolab Inc. reported strong second-quarter 2026 financial results, with revenue reaching USD 4.42 billion, representing a 9.70 percent year-over-year increase. The company delivered diluted earnings per share of USD 1.90, which beat the consensus estimate of USD 2.08 according to MarketBeat data, while total revenue also surpassed analyst expectations of USD 4.38 billion.
Following the positive earnings report, investment bank UBS raised its price target for Ecolab stock from USD 342.00 to USD 344.00 on October 5, 2026, maintaining a Buy rating. This analyst action reflects confidence in the company's operational performance and suggests the current market valuation remains below the primary-market benchmark.
Ecolab's stock is trading with a price-to-earnings ratio of 38.58 and a market capitalization of USD 80.8 billion as of October 20, 2026. The company operates across four segments including water treatment, hygiene, infection prevention, and specialty chemical services, positioning it for continued growth in these industrial sectors.
The upcoming third-quarter results scheduled for October 27, 2026, will be closely watched to determine if the recent revenue growth trajectory can be sustained. Analysts are using the next earnings report to assess whether the company can maintain its momentum given the current valuation levels.
๐ Q2 revenue rose 9.70% to USD 4.42 billion.
๐ฐ EPS hit USD 1.90, missing the USD 2.08 estimate.
๐ฆ UBS raised price target to USD 344.00 on Oct 5.
โญ Analysts maintained a Buy rating after earnings beat.
Ecolab Inc. reported strong second-quarter financial results, posting revenue of USD 4.42 billion, which represents a 9.70 percent year-over-year increase. The company also delivered earnings per share of USD 2.09, beating the consensus estimate of USD 2.08 by a small margin. These figures highlight continued growth in the specialty chemicals and industrial services sector.
Institutional investor Assenagon Asset Management significantly increased its position in Ecolab during the third quarter, adding 103,601 shares to its existing holdings. This aggressive accumulation resulted in a total stake of 114,521 shares valued at approximately USD 31.4 million according to recent filings. The move by Assenagon underscores growing institutional confidence in Ecolab's operational performance and future outlook.
Looking ahead, Ecolab is scheduled to release its third-quarter results on October 27, 2026, before the US market opens, followed by a webcast at 1:00 p.m. Eastern Time. Analysts currently estimate quarterly revenue of USD 4.70 billion and earnings per share between USD 2.13 and USD 2.23. The company recently acquired CoolIT Systems to expand its high-tech capabilities, contributing to its broader strategic growth initiatives.
Ecolab stock is trading at EUR 257.70 as of October 19, 2026, with a market capitalization of USD 80.9 billion. The stock has a 52-week range between USD 243.15 and USD 309.27. With institutional ownership standing at 74.91 percent, the company remains a key focus for hedge funds and asset managers tracking industrial sector performance.
๐ Q2 revenue rose 9.70% to USD 4.42 billion, beating EPS estimates.
๐ฐ Assenagon increased stake by 948.70%, now holding USD 31.4 million.
๐ญ Acquired CoolIT Systems to expand high-tech industrial solutions portfolio.
๐ Q3 results due October 27, 2026; analysts estimate USD 4.70B revenue.
๐ถ Stock trades at EUR 257.70 with USD 80.9 billion market cap.
๐ Ecolab reported second-quarter revenue of USD 4.42 billion, marking a 9.70 percent year-over-year increase.
๐ฐ The company achieved earnings per share of USD 2.09, surpassing the analyst consensus estimate of USD 2.08.
๐ Assenagon Asset Management increased its Ecolab stake by 948.70 percent in Q3, adding 103,601 shares.
๐ผ The total position held by Assenagon is now valued at approximately USD 31.4 million.
๐ Ecolab is scheduled to release third-quarter results on October 27, 2026, before the US market opens.
๐ฏ Analysts estimate Q3 revenue of USD 4.70 billion and EPS guidance between USD 2.13 and USD 2.23.
๐ญ Ecolab recently acquired CoolIT Systems to expand its high-tech industrial solutions portfolio.
๐ Institutional investors collectively hold 74.91 percent of Ecolab's outstanding shares.
๐ถ The stock trades at EUR 257.70 with a market capitalization of USD 80.9 billion.
Bullish Signals
Revenue grew 9.70% to USD 4.42 billion.
EPS beat estimates at USD 2.09.
Assenagon increased stake by 948.70%.
Acquired CoolIT Systems for high-tech expansion.
Bullish Signals
Ecolab reported second-quarter revenue of USD 4.42 billion, representing a robust 9.70 percent year-over-year growth.
The company beat earnings per share expectations with actual results of USD 2.09 versus the consensus estimate of USD 2.08.
Institutional investor Assenagon Asset Management aggressively increased its stake by 948.70 percent, adding over 100,000 shares.
The significant accumulation by Assenagon indicates strong institutional confidence in Ecolab's business fundamentals and growth trajectory.
Ecolab successfully expanded its high-tech capabilities through the acquisition of CoolIT Systems.
Ecolab Inc. received a price target update from RBC Capital, which maintained its Buy rating and set a new USD 337.00 price objective for the stock on October 14, 2026. This target represents a 15.69% premium over Ecolab's NYSE trading price of USD 291.32 recorded on October 16, 2026, providing analysts with a clear valuation reference point in the company's home currency.
The company reported strong financial performance for its second quarter ended June 30, 2026, with revenue reaching USD 4.42 billion and net income attributable to common shareholders totaling USD 534.9 million. Diluted earnings per share stood at USD 1.90, while operating cash flow was reported at USD 729.5 million, offering a solid anchor for the ongoing valuation discussion.
Ecolab operates across four segments providing water, hygiene, and infection prevention solutions, including its Global Water and Global Life Sciences divisions. As of October 16, 2026, the company held a market capitalization of USD 81.7 billion with a P/E ratio of 39.07, trading within a 52-week range between USD 243.15 and USD 309.27.
The stock traded at EUR 259.05 on the Xetra exchange in Germany, reflecting continued investor interest alongside its primary listing on the NYSE. With an average daily trading volume of approximately 1.3 million shares, Ecolab maintains active liquidity as it prepares for its next scheduled reporting date on October 27, 2026.
๐ RBC maintains Buy rating with USD 337.00 target for ECL.
๐ฐ Q2 revenue hit USD 4.42B and net income USD 534.9M.
๐ต Operating cash flow reached USD 729.5M in second quarter.
๐ Stock trades at P/E of 39.07 with USD 81.7B market cap.
๐ Next earnings report scheduled for October 27, 2026.
๐ RBC Capital analyst Ashish Sabadra maintained a Buy rating and established a USD 337.00 price target for Ecolab Inc.
๐ฐ The new analyst target is 15.69% higher than the current NYSE trading price of USD 291.32 as of October 16, 2026.
๐ Ecolab reported Q2 revenue of USD 4.42 billion and net income of USD 534.9 million for the period ended June 30, 2026.
๐ต Operating cash flow for the second quarter reached USD 729.5 million, supporting the company's valuation metrics.
๐ The stock trades at a P/E ratio of 39.07 with a market capitalization of USD 81.7 billion as of October 16, 2026.
๐ Ecolab provides water, hygiene, and infection prevention solutions across four operating segments including Global Water.
๐ The company's next scheduled earnings reporting date is set for October 27, 2026.
๐ The stock's 52-week trading range spans from USD 243.15 to USD 309.27, with the current price near the upper end.
๐ฉ๐ช German investors can reference a EUR 259.05 quotation at Lang & Schwarz alongside the primary NYSE listing.
Bullish Signals
RBC maintained Buy rating with $337.00 price target.
Bullish Signals
RBC Capital analyst Ashish Sabadra maintained a Buy rating and set a USD 337.00 price target, implying significant upside potential relative to current market levels.
The company delivered robust Q2 financial results with revenue of USD 4.42 billion and net income of USD 534.9 million, demonstrating strong operational execution.
Ecolab generated substantial operating cash flow of USD 729.5 million in the second quarter, providing a healthy liquidity buffer for future investments or dividends.
The stock is trading near its 52-week high of USD 309.27, indicating strong investor confidence and bullish market sentiment around the current valuation.
Ecolab Inc. (ECL) traded at USD 280.93 on October 12, 2026, with a market capitalization of USD 79.1 billion. The stock's trailing P/E ratio stood at 37.7, reflecting high earnings expectations from the market. The company operates in specialty chemicals, providing water, hygiene, and infection prevention solutions to industrial, foodservice, healthcare, and hospitality sectors.
Analyst sentiment remains positive, with UBS raising its price target for Ecolab from USD 342 to USD 344 on October 5, 2026, while maintaining a Buy rating. The new target represents a significant premium over the current trading price. Investors are awaiting the company's third-quarter 2026 results, which are scheduled to be reported before the market opens on October 27, 2026.
Ecolab combines recurring service activities with chemical products and technical solutions, creating a diversified revenue stream across multiple markets. The stock has traded within a 52-week range of USD 243.15 to USD 309.27, currently sitting approximately 9.17 percent below its yearly high. Trading volume on the specified date was notably lower than the average daily volume.
๐ ECL trades at $280.93 with a $79.1B market cap.
๐ UBS raised ECL price target to $344 on Buy rating.
๐ ECL reports Q3 2026 results on October 27, 2026.
๐ฐ ECL trades at a trailing P/E ratio of 37.7.
๐ Stock is down 9.17% from its 52-week high of $309.27.
๐ Ecolab stock traded at USD 280.93 with a market cap of USD 79.1 billion as of October 12, 2026.
๐ UBS raised its price target for ECL from USD 342 to USD 344 while maintaining a Buy rating.
๐ The company is scheduled to report third-quarter 2026 results on October 27, 2026.
๐ฐ Ecolab's trailing P/E ratio was 37.7, indicating high earnings expectations from the market.
๐ญ The company operates in specialty chemicals serving industrial, foodservice, healthcare, and hospitality markets.
๐ The stock is currently trading 9.17 percent below its 52-week high of USD 309.27.
๐ง Ecolab combines recurring service activity with chemical products and technical solutions.
Bullish Signals
UBS raised price target to USD 344 with Buy rating.
Operates in specialty chemicals for industrial and healthcare markets.
Bullish Signals
UBS raised its price target for Ecolab from USD 342 to USD 344 while maintaining a Buy rating, signaling continued analyst confidence in the company's prospects.
The company operates in specialty chemicals with water, hygiene, and infection prevention solutions serving customers across industrial, foodservice, healthcare, and hospitality markets.
Ecolab Inc. reported strong second-quarter financial results for the fiscal year 2026, with revenue rising 9.70 percent to USD 4.42 billion. The company beat analyst expectations, posting adjusted earnings per share of USD 2.09 against a consensus estimate of USD 2.08, while total revenue exceeded the forecast of USD 4.38 billion.
Following the positive quarterly performance, Ecolab has scheduled its third-quarter results webcast for October 27, 2026, at 1:00 p.m. ET. The company provided forward-looking guidance for the upcoming quarter, setting adjusted earnings per share between USD 2.13 and USD 2.23.
This quarterly outlook aligns with a raised full-year adjusted earnings per share projection ranging from USD 8.05 to USD 8.25. As of late September 2026, the stock traded at USD 274.78, sitting approximately 11 percent below its 52-week high of USD 309.27.
The company operates within the Basic Materials and Specialty Chemicals sectors with a market capitalization of roughly USD 77.3 billion as of early October 2026. Investors are awaiting the upcoming earnings release to assess whether the raised guidance holds against current market conditions.
๐ Q2 revenue rose 9.70% to USD 4.42 billion.
๐ฐ Adjusted EPS hit USD 2.09, beating estimates.
๐ Raised full-year adjusted EPS outlook to USD 8.05-8.25.
๐ Q3 results release scheduled for October 27, 2026.
๐ฏ Q3 adjusted EPS guidance set between USD 2.13-2.23.
๐ Ecolab reported second-quarter revenue of USD 4.42 billion, representing a 9.70 percent increase year-over-year.
๐ฐ Adjusted earnings per share reached USD 2.09, surpassing the consensus estimate of USD 2.08.
๐ The company raised its full-year adjusted earnings per share outlook to a range of USD 8.05 to USD 8.25.
๐ Third-quarter results are scheduled for release via webcast on October 27, 2026, at 1:00 p.m. ET.
๐ฏ Q3 adjusted earnings per share guidance is set between USD 2.13 and USD 2.23.
๐ Stock price was USD 274.78 on September 30, 2026, trading 11.15 percent below its 52-week high.
๐ข Ecolab operates in the Basic Materials and Specialty Chemicals sectors with a market cap of USD 77.3 billion.
Bullish Signals
Revenue grew 9.70% to USD 4.42 billion.
Beat EPS estimates with USD 2.09 result.
Revenue exceeded expectations at USD 4.38 billion.
Ecolab Inc. reported second-quarter 2026 results showing revenue of USD 4.42 billion and earnings of USD 534.9 million, slightly exceeding analyst expectations for both metrics. The company's profit margin stood at 12.11 percent, with earnings per share reaching USD 2.09 against a consensus estimate of USD 2.08. This performance indicates continued operational scale and the ability to meet market demands despite a slight decline in the stock price on the reporting day.
Analyst sentiment remains cautiously positive, with an average twelve-month price target of USD 324.95, which sits approximately 20 percent above the closing price of USD 270.19 recorded on September 21, 2026. Wells Fargo recently maintained an Equal-Weight rating while raising its specific price target from USD 275 to USD 295, reflecting a measured but constructive outlook for the industrial services provider.
Looking ahead, investors will focus on the upcoming Q3 earnings report scheduled for November 3, 2026, where consensus estimates project revenue of approximately USD 4.70 billion and EPS of USD 2.17. The company's valuation is currently anchored at a market capitalization of USD 75.54 billion, with the stock trading within its fifty-two-week range as analysts monitor margin delivery and future growth trajectories.
Market data highlights Ecolab's position in the Industrials sector under Commercial Services and Supplies, with significant attention on whether the company can sustain its efficiency-driven growth model. The gap between current analyst targets and the actual closing price suggests potential upside if the firm continues to capitalize on water demand and operational efficiencies in the coming quarters.
๐ Ecolab Q2 revenue hit $4.42B, beating estimates by $40M.
๐ฐ EPS reached $2.09, surpassing consensus by 0.48%.
๐ฏ Analyst price target averages $324.95, a 20.3% premium.
๐ฆ Wells Fargo raised Ecolab price target to $295.
๐ Q3 results scheduled for November 3 with $4.70B revenue estimate.
๐ Ecolab generated Q2 2026 revenue of USD 4.42 billion, beating the consensus estimate of USD 4.38 billion by USD 40 million.
๐ฐ The company reported Q2 earnings of USD 534.9 million with a profit margin of 12.11 percent.
๐ Earnings per share reached USD 2.09, surpassing the consensus estimate of USD 2.08 by approximately 0.48 percent.
๐ฏ The average twelve-month analyst price target is USD 324.95, representing a 20.3 percent premium over the September 21 closing price.
๐ฆ Wells Fargo raised its price target from USD 275 to USD 295 while maintaining an Equal-Weight rating on July 30, 2026.
๐ Ecolab is scheduled to report Q3 2026 results on November 3, 2026, with consensus estimates of USD 4.70 billion revenue and USD 2.17 EPS.
๐ข The company holds a market capitalization of USD 75.54 billion as of September 21, 2026.
๐ Ecolab stock closed at USD 270.19 on the New York Stock Exchange, down 0.27 percent from the prior session.
๐ The fifty-two-week trading range spans from USD 243.15 to USD 309.27, with the current price near the lower end of the spectrum.
Bullish Signals
Revenue beat estimates by USD 40 million.
EPS beat indicates effective cost management.
Analysts see upside with average target of USD 324.95.
Wells Fargo raised valuation target to USD 295.
Risk Factors
Stock edged lower on Sept 21 despite positive earnings.
Price far below 52-week high of $309.27.
Bullish Signals
Ecolab beat Q2 revenue estimates by USD 40 million, demonstrating strong demand for its water and efficiency solutions.
The company delivered an EPS beat of 0.48 percent, indicating effective cost management and operational execution.
Analysts maintain a significant upside potential with an average price target of USD 324.95 versus the current trading price.
Wells Fargo increased its valuation target by 7.3 percent to USD 295, signaling confidence in the company's growth trajectory.
Risk Factors
The stock edged lower on September 21, closing down 0.27 percent despite positive earnings results.
The current trading price is significantly below the fifty-two-week high of USD 309.27, suggesting potential volatility or lack of immediate momentum.
Ecolab Inc. (NYSE: ECL) closed at $269.61 on September 18, 2026, trading approximately 21.5% below the average analyst price target of $327.56. Despite a significant 59% share price run since 2025, Wall Street maintains a consensus 'Moderate Buy' rating with 18 buy recommendations against three holds, suggesting analysts still see substantial upside potential from current levels.
The company currently trades at a trailing price-to-earnings ratio of roughly 36.15 and offers a dividend yield of about 1.05%, reflecting a premium valuation that discounts expected future profit growth. With a market capitalization of approximately $75.58 billion, Ecolab is viewed as a defensive growth name with exposure to structural themes like water stewardship and hygiene regulation, though its elevated multiple leaves little room for error if earnings disappoint.
Recent trading activity shows elevated investor interest, with daily volume reaching 2.57 million shares compared to an average of 1.25 million. The stock has consolidated in the mid-range of its 52-week band, sitting about 10.9% above the yearly low and 12.8% below the high. Investors are closely watching upcoming quarterly results and guidance updates to determine if they can justify the current valuation and support further appreciation toward analyst targets.
๐ Shares trade 21.5% below the $327.56 average analyst price target.
๐ฐ Ecolab trades at a trailing P/E of 36.15 with 1.05% yield.
๐ข Market cap stands at $75.58 billion as of September 18, 2026.
โ ๏ธ Elevated valuation poses risk of multiple compression in risk-off markets.
๐ Ecolab Inc. closed at $269.61 on September 18, 2026, leaving shares roughly 21.5% below the average analyst price target of $327.56.
๐ The stock has rallied approximately 59% since 2025, prompting questions about whether the current valuation in the mid-30s earnings multiple is fully priced.
๐ฐ Ecolab trades at a trailing P/E ratio of around 36.15 with a dividend yield of roughly 1.05%, reflecting premium growth expectations.
๐ Daily trading volume surged to 2.57 million shares on September 18, significantly above the average daily volume of 1.25 million shares.
๐ข The company holds a market capitalization of approximately $75.58 billion as of the September 18, 2026 close.
๐ก๏ธ Analysts maintain a 'Moderate Buy' consensus rating based on one strong buy, 17 buy, and three hold recommendations.
๐ The stock trades in a range between $243.15 and $309.27 over the past 52 weeks, currently positioned mid-range.
๐ง Ecolab operates as a water, hygiene, and infection-prevention specialist with exposure to structural themes like water stewardship.
โ ๏ธ Elevated valuation is cited as a key risk, with potential multiple compression in risk-off market environments.
Bullish Signals
Analysts maintain 'Moderate Buy' rating with $327.56 price target.
Stock gained 59% since 2025 showing strong momentum.
Risk Factors
Earnings multiple of 36.15 exceeds market averages.
59% price run since 2025 suggests full valuation.
Bullish Signals
Analysts maintain a consensus 'Moderate Buy' rating with 18 buy recommendations against three holds, implying significant upside to the $327.56 price target.
The stock has delivered a substantial 59% share price run since 2025, demonstrating strong market momentum and investor confidence in the business model.
Risk Factors
The current earnings multiple of roughly 36.15 is noticeably above broader market averages, suggesting the stock already discounts a healthy portion of future profit growth.
A 59% price run since 2025 has prompted commentary questioning whether the valuation looks full and if there is enough room for further rerating.
Ecolab Inc. reported robust second-quarter 2026 financial results, driving its stock price to trade near recent highs as of September 6, 2026. The company posted net sales of $4,415.4 million, representing a 10% year-over-year increase from the prior period, signaling strong top-line growth in its core hygiene and water treatment segments. This performance was underpinned by improved profitability where pricing power and productivity gains successfully offset rising commodity and investment costs.
Operating income for the quarter rose 7% to $757.9 million on a reported basis, while adjusted operating income grew 10% to $809.0 million. Diluted earnings per share reached $1.90, with adjusted EPS climbing 11% year-over-year to $2.09. These figures reflect sustained investor confidence in Ecolab's ability to deliver consistent value through a combination of revenue expansion and margin optimization.
Looking ahead, Ecolab reiterated upbeat guidance for the third quarter of 2026, projecting adjusted diluted EPS between $2.13 and $2.23. The company maintains a steady dividend profile with a quarterly payout of $0.73 per share, resulting in an annualized yield of approximately 1.0%. Analysts forecast full-year 2026 earnings per share of roughly $8.17, supporting the stock's valuation as a premium income-generating holding within the specialty chemicals sector.
Ecolab continues to diversify its revenue streams with digital sales reaching $121 million in Q2 2026, a significant 27% year-over-year increase. This growth highlights the increasing importance of connected and data-driven offerings within its portfolio. Trading at a price-to-earnings ratio of 37.47 based on trailing earnings, the stock consolidates near its intraday high of $280.50, reflecting strong market metrics and long-term investor interest.
๐ Q2 net sales rose 10% to $4,415.4 million.
๐ฐ Adjusted operating income grew 10% to $809.0 million.
๐ฎ Q3 adjusted EPS guidance set between $2.13-$2.23.
๐ Digital sales surged 27% year-over-year to $121 million.
๐ Stock trades at $279.28 with a P/E of 37.47.
๐ Ecolab reported Q2 2026 net sales of $4,415.4 million, marking a 10% increase from the same period in 2025.
๐ฐ Adjusted operating income grew 10% to $809.0 million as pricing and productivity gains offset higher input costs.
๐ Reported diluted EPS reached $1.90, while adjusted EPS rose 11% year-over-year to $2.09.
๐ฎ The company provided Q3 2026 guidance for adjusted diluted EPS in the range of $2.13 to $2.23.
๐ต Ecolab maintains a quarterly dividend of $0.73, yielding approximately 1.0% at current trading prices.
๐ Digital sales surged 27% year-over-year to reach $121 million in the second quarter of 2026.
๐ The stock trades near recent highs with a market capitalization of $78.31 billion as of September 5, 2026.
๐ข Ecolab serves key sectors including hotels, restaurants, healthcare facilities, and industrial customers.
๐ Analysts forecast full-year 2026 earnings per share of approximately $8.17 based on current sell-side data.
๐ The stock closed at $279.28 with a price-to-earnings ratio of 37.47 based on trailing earnings.
Bullish Signals
Net sales grew 10% to $4,415.4M in Q2 2026.
Bullish Signals
Ecolab reported strong Q2 2026 net sales growth of 10% to $4,415.4 million, driven by solid performance in its core hygiene and water treatment businesses.
Adjusted operating income increased 10% year-over-year to $809.0 million, demonstrating improved profitability despite higher commodity and investment costs.
The company delivered adjusted diluted EPS of $2.09, an 11% increase from the prior year, reinforcing investor confidence in its earnings trajectory.
Ecolab reiterated upbeat guidance for Q3 2026 with adjusted diluted EPS expected between $2.13 and $2.23, indicating continued growth momentum.
Digital sales grew significantly by 27% to reach $121 million in Q2 2026, highlighting the successful expansion of its data-driven product portfolio.
The stock is trading near recent highs with a market capitalization of $78.31 billion, reflecting strong market sentiment following the earnings release.
Ecolab Inc. CEO Christophe Beck sold 17,862 shares of the company's common stock on August 18, 2026, according to a Form 4 filed with the SEC on August 20, 2026. The transaction was executed at a weighted average price of $280.138 per share, with individual trade prices ranging between $279.950 and $280.400.
Following the sale, Beck retains direct ownership of 72,932.118 shares of Ecolab common stock. The filing also discloses his indirect beneficial ownership of approximately 3,221 shares held through units in the Ecolab Savings Plan (401(k)), which includes recent additions to his plan holdings since his last report.
The transaction was conducted under transaction code S, indicating a sale not part of a pre-arranged trading plan. The Form 4 was signed by Corinne Lawson acting as attorney-in-fact for Beck, who serves as the Chairman, President, and CEO of Ecolab Inc.
๐ CEO Christophe Beck sold 17,862 shares at $280.138 per share.
๐ฆ Beck retains 72,932 direct shares and 3,221 indirect shares via 401k.
๐ Form 4 filed August 20, 2026, confirms transaction details.
๐ Sale executed by attorney-in-fact Corinne Lawson on behalf of Beck.
๐ Ecolab CEO Christophe Beck sold 17,862 shares of common stock on August 18, 2026.
๐ฐ The sale was executed at a weighted average price of $280.138 per share.
๐ฆ Beck retains direct ownership of 72,932.118 shares following the transaction.
๐ A Form 4 filed on August 20, 2026, details the sale and current beneficial ownership.
๐ Indirect holdings include approximately 3,221 shares via the Ecolab Savings Plan (401k).
โ๏ธ The transaction was signed by attorney-in-fact Corinne Lawson on behalf of Beck.
Risk Factors
CEO sold 17,862 shares, reducing holdings to 72,932.
Risk Factors
CEO Christophe Beck sold 17,862 shares of Ecolab common stock at an average price of $280.138, reducing his direct holdings to 72,932.118 shares.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)